SenthilKumar Gopika, Katunaric Boran, Zirgibel Zachary, Lindemer Brian, Jaramillo-Torres Maria J, Bordas-Murphy Henry, Schulz Mary E, Pearson Paul J, Freed Julie K
Department of Physiology, Medical College of Wisconsin.
Cardiovasular Center, Medical College of Wisconsin.
bioRxiv. 2023 Jun 6:2023.06.02.543341. doi: 10.1101/2023.06.02.543341.
Elevated plasma ceramides independently predict adverse cardiac events and we have previously shown that exposure to exogenous ceramide induces microvascular endothelial dysfunction in arterioles from otherwise healthy adults (0-1 risk factors for heart disease). However, evidence also suggests that activation of the shear-sensitive, ceramide forming enzyme neutral sphingomyelinase (NSmase) enhances vasoprotective nitric oxide (NO) production. Here we explore a novel hypothesis that acute ceramide formation through NSmase is necessary for maintaining NO signaling within the human microvascular endothelium. We further define the mechanism through which ceramide exerts beneficial effects and discern key mechanistic differences between arterioles from otherwise healthy adults and patients with coronary artery disease (CAD).
Human arterioles were dissected from otherwise discarded surgical adipose tissue (n=123), and vascular reactivity to flow and C2-ceramide was assessed. Shear-induced NO production was measured in arterioles using fluorescence microscopy. Hydrogen peroxide (HO) fluorescence was assessed in isolated human umbilical vein endothelial cells.
Inhibition of NSmase in arterioles from otherwise healthy adults induced a switch from NO to HO-mediated flow-induced dilation within 30 minutes. In endothelial cells, NSmase inhibition acutely increased HO production. Endothelial dysfunction in both models was prevented by treatment with C2-ceramide, S1P, and an agonist of S1P-receptor 1 (S1PR1), while the inhibition of S1P/S1PR1 signaling axis induced endothelial dysfunction. Ceramide increased NO production in arterioles from healthy adults, an effect that was diminished with inhibition of S1P/S1PR1/S1PR3 signaling. In arterioles from patients with CAD, inhibition of NSmase impaired dilation to flow. This effect was not restored with exogenous S1P. Although, inhibition of S1P/S1PR3 signaling impaired normal dilation to flow. Acute ceramide administration to arterioles from patients with CAD also promoted HO as opposed to NO production, an effect dependent on S1PR3 signaling.
These data suggest that despite key differences in downstream signaling between health and disease, acute NSmase-mediated ceramide formation and its subsequent conversion to S1P is necessary for proper functioning of the human microvascular endothelium. As such, therapeutic strategies that aim to significantly lower ceramide formation may prove detrimental to the microvasculature.
血浆神经酰胺水平升高可独立预测不良心脏事件,我们之前已经表明,暴露于外源性神经酰胺会导致健康成年人(心脏病风险因素为0 - 1)的小动脉微血管内皮功能障碍。然而,也有证据表明,剪切敏感的神经酰胺形成酶中性鞘磷脂酶(NSmase)的激活会增强血管保护性一氧化氮(NO)的生成。在此,我们探讨一个新的假说,即通过NSmase急性形成神经酰胺对于维持人类微血管内皮细胞内的NO信号传导是必要的。我们进一步明确神经酰胺发挥有益作用的机制,并辨别健康成年人与冠状动脉疾病(CAD)患者小动脉之间关键的机制差异。
从废弃的手术脂肪组织中解剖出人类小动脉(n = 123),评估血管对血流和C2 - 神经酰胺的反应性。使用荧光显微镜测量小动脉中剪切诱导的NO生成。在分离的人脐静脉内皮细胞中评估过氧化氢(HO)荧光。
在健康成年人的小动脉中,抑制NSmase会在30分钟内导致从NO介导转变为HO介导的血流诱导舒张。在内皮细胞中,抑制NSmase会急性增加HO的生成。用C2 - 神经酰胺、S1P和S1P受体1(S1PR1)激动剂处理可预防两种模型中的内皮功能障碍,而抑制S1P/S1PR1信号轴会诱导内皮功能障碍。神经酰胺增加健康成年人小动脉中的NO生成,抑制S1P/S1PR1/S1PR3信号传导会减弱这种作用。在CAD患者的小动脉中,抑制NSmase会损害对血流的舒张反应。外源性S1P不能恢复这种作用。尽管如此,抑制S1P/S1PR3信号传导会损害正常的血流舒张反应。对CAD患者的小动脉急性给予神经酰胺也会促进HO生成而非NO生成,这种作用依赖于S1PR3信号传导。
这些数据表明,尽管健康与疾病状态下下游信号传导存在关键差异,但急性NSmase介导的神经酰胺形成及其随后转化为S1P对于人类微血管内皮细胞的正常功能是必要的。因此,旨在显著降低神经酰胺形成的治疗策略可能对微血管系统有害。